Stock Events

Stock Events

C4 Therapeutics (CCCC) Q1 2023 Earnings

4MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-0.76

-0.69

-0.63

-0.56

Details

Expected EPS

-0.75

Actual EPS

-0.71

Surprise EPS

0.04

Surprise Percent

+5.33%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.71 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.